Deeper Data.
Better Outcomes.

PointClickCare Life Sciences offers access to the richest, continuously updated, and unrivaled data sets of aging and vulnerable populations in long-term and post-acute patient care.

Inform Decisions with Data

Unparalleled Insights in an Important Demographic

For more than 20 years, PointClickCare has collected long-term and post-acute care data from the vast majority of senior care facilities across North America. Our unique dataset offers unrivaled patient insights at every stage of the healthcare journey, capable of fundamentally informing scientific research and the commercialization of new standards of care and revolutionary treatments.

Continuously updated, longitudinal data provide insights supporting:

Key strategic choices in the planning, implementation, and management of drug development processes
Commercialization planning
Sales strategies
Clinical trials

A Growing Population = Opportunity

Life expectancies are increasing and birth rates are falling in most developed countries, leading to aging populations. The 65+ age demographic is set to double in size in the U.S. by 2050, which will inevitably see drastic increases in the prevalence of age-related diseases. Unfortunately, this population faces delays in access to the same standards of care the general population receives, fueled by misconceptions regarding their ability to withstand or pay for treatment. In reality, members of this group take an average of six medications, representing $20B in branded drug sales and a rapidly growing market opportunity. PointClickCare Life Science aims to change the landscape for the aging population by supporting the innovation of urgently-needed therapeutic solutions. We offer health professionals and researchers comprehensive data sets that can inform drug development, support post-market clinical studies, and drive commercialization. PointClickCare Life Sciences data offer unparalleled insights based on 6 years of patient journeys with respiratory, rheumatology, urological, and neurological conditions and indications, including, but not limited to, Alzheimer’s disease, Parkinson’s disease, epilepsy, and diabetes.

A decade of longitudinal data
Over 20 million unique patients
~9 billion daily vitals records
Almost 2 billion ADL records
Over 73 million MDS records
83 million assessment records and growing (Functional Scores, ADL, BIMS, CPS, PHQ-9)
7x data volume of any other long-term care (LTC) data source
35 or more daily observations per patient
Weekly data updates (near real-time)
Blood pressure, blood sugar, height, O2 sat, pain, pulse, respiration, temperature, and weight

Trial protocol validation and optimization
Health economics and outcomes
Site selection

Pre-market analysis and/or competitive intelligence
Post-market surveillance
Epidemiology

Disease burden and unmet need identification
Disease state publications
Trigger signaling

Power Your Research

PointClickCare Life Sciences offers access to the industry’s largest data set covering aging population patient journeys, disease progression, comorbidities, symptom onset and resolution, and correlation between treatments and outcomes. Insights gained from this data can empower your decision-making during drug development programs, supporting robust study conclusions, and advancing research into effective treatment options in long-term and post-acute care. Let us assist you in making informed decisions throughout the drug development process.

Access Your Dataset

Optimize Clinical Trial Planning and Deployment

Comprehensive insights into drug utilization, adverse events, burden of care, and quality of life (including daily health outcomes and activities of daily living) in diverse patient populations are crucial for accurate post-market reporting. Our data enables your team to better understand treatments’ long-term effects and safety profiles. The extensive data set helps to identify trends, assess the impact on patient well-being, and optimize therapeutic strategies. Providing support for clinical development and Phase IV studies to aid in study protocol definition, site selection, and maximize recruitment. This granular information ensures more accurate and reliable results, ultimately enhancing the effectiveness and safety of treatments.

Access Your Dataset

Drive Your Commercial Strategy

Unlock the full potential of your commercial launch by leveraging detailed data on underdiagnosed populations, prescription patterns, prescription switching, and off-label prescribing. Our depth of data provides deep insights into these critical areas, enabling you to refine launch strategies and optimize sale tactics to ensure a successful market entrance and sustained growth.

Access Your Dataset

Clinical Dataset

This dataset includes resident health activity such as reason and treatment, and outcomes. It also provides detailed data points including outcomes & biomarkers, diagnoses and co-morbidities, treatment and therapies, encounters and MDS assessments.

Learn More

Commercial Dataset

This real-world dataset is tailored to your specific market by filtering only the relevant therapies and diagnoses. It empowers clients to interpret the data in ways that align with their unique strategy.

Learn More

Market Overview Dashboard

This tool provides easy-to-read visual summaries of current market trends for healthcare providers, facilities, and pharmacies. It helps align your sales force at national and territory levels, and quickly understand essential market dynamics such as diagnosis and therapy distribution.

Learn More

Orders Overview Dashboard

This set of visualizations summarizes real-world data on order behavior, allowing you to understand all stages of the sales cycle and expedite therapy delivery to patients. Quickly visualize and understand switching behavior and monitor trends over time to measure the effectiveness of your sales strategy.

Learn More